Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies.

MLA

Heijkants, R. C., et al. “Targeting MDMX and PKCδ to Improve Current Uveal Melanoma Therapeutic Strategies.” Oncogenesis, vol. 7, no. 3, Mar. 2018, p. 33. EBSCOhost, https://doi.org/10.1038/s41389-018-0041-y.

APA

Heijkants, R. C., Nieveen, M., Hart, K. C. ’t, Teunisse, A. F. A. S., & Jochemsen, A. G. (2018). Targeting MDMX and PKCδ to improve current uveal melanoma therapeutic strategies. Oncogenesis, 7(3), 33. https://doi.org/10.1038/s41389-018-0041-y

Chicago

Heijkants, R C, M Nieveen, K C ’t Hart, A F A S Teunisse, and A G Jochemsen. 2018. “Targeting MDMX and PKCδ to Improve Current Uveal Melanoma Therapeutic Strategies.” Oncogenesis 7 (3): 33. doi:10.1038/s41389-018-0041-y.